303 related articles for article (PubMed ID: 37907436)
21. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
22. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
[TBL] [Abstract][Full Text] [Related]
23. Variation in out of pocket health care costs for individuals with anxiety disorders by type of insurance coverage.
Tucker K; Dark T; Harman JS
J Anxiety Disord; 2018 Aug; 58():18-22. PubMed ID: 29935451
[TBL] [Abstract][Full Text] [Related]
24. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
25. Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis.
Gitlin M; McGarvey N; Shivaprakash N; Cong Z
J Manag Care Spec Pharm; 2023 Jun; 29(6):659-670. PubMed ID: 37276034
[No Abstract] [Full Text] [Related]
26. Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India.
Wadasadawala T; Mohanty SK; Sen S; Kanala TS; Maiti S; Puchali N; Gupta S; Sarin R; Parmar V
Lancet Reg Health Southeast Asia; 2024 May; 24():100346. PubMed ID: 38756158
[TBL] [Abstract][Full Text] [Related]
27. Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City.
Xie P; Li X; Guo F; Zhang D; Zhang H
Front Public Health; 2023; 11():1146914. PubMed ID: 37228711
[TBL] [Abstract][Full Text] [Related]
28. Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.
Khera R; Valero-Elizondo J; Okunrintemi V; Saxena A; Das SR; de Lemos JA; Krumholz HM; Nasir K
JAMA Cardiol; 2018 Aug; 3(8):729-738. PubMed ID: 29971325
[TBL] [Abstract][Full Text] [Related]
29. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
[TBL] [Abstract][Full Text] [Related]
30. Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram.
Hughes DR; Espinoza W; Fein S; Rula EY; McGinty G
JAMA Netw Open; 2023 Mar; 6(3):e234893. PubMed ID: 36972047
[TBL] [Abstract][Full Text] [Related]
31. Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance.
Fu SJ; Rose L; Dawes AJ; Knowlton LM; Ruddy KJ; Morris AM
JAMA Netw Open; 2021 Dec; 4(12):e2134282. PubMed ID: 34935922
[TBL] [Abstract][Full Text] [Related]
32. Out-of-Pocket Spending for Thumb Carpometacarpal Arthritis: Capitation Matters.
Billig JI; Lu YT; Kelley BP; Chung KC; Sears ED
Hand (N Y); 2021 Nov; 16(6):818-826. PubMed ID: 32088982
[No Abstract] [Full Text] [Related]
33. Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon".
Doshi JA; Li P; Pettit AR; Dougherty JS; Flint A; Ladage VP
Am J Manag Care; 2017 Mar; 23(3 Suppl):S39-S45. PubMed ID: 29648739
[TBL] [Abstract][Full Text] [Related]
34. The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis.
Lindsay D; Schofield P; Nabukalu D; Roberts MJ; Yaxley J; Quinn S; Richards N; Frydenberg M; Gardiner R; Lawrentschuk N; Juraskova I; Murphy DG; Gordon LG
Aust Health Rev; 2024 Feb; 48():172-181. PubMed ID: 38342484
[TBL] [Abstract][Full Text] [Related]
35. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
36. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
37. Use and Out-of-Pocket Cost of Sacubitril-Valsartan in Patients With Heart Failure.
Shore S; Basu T; Kamdar N; Brady P; Birati E; Hummel SL; Chopra V; Nallamothu BK
J Am Heart Assoc; 2022 Sep; 11(17):e023950. PubMed ID: 36000415
[TBL] [Abstract][Full Text] [Related]
38. Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.
Feng K; Russo M; Maini L; Kesselheim AS; Rome BN
JAMA Health Forum; 2024 Mar; 5(3):e235429. PubMed ID: 38551589
[TBL] [Abstract][Full Text] [Related]
39. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
[TBL] [Abstract][Full Text] [Related]
40. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China.
Yong M; Xianjun X; Jinghu L; Yunyun F
Aust Health Rev; 2018 Feb; 42(1):39-44. PubMed ID: 28263706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
